Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.70
Shares Outstanding176.7M
Average Volume (10 days)1.1M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.83)
Sales (TTM)$7.57
Book Value (MRQ)$15.88
Cash Flow (TTM)$0.17
Cash (MRQ)$7.86

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy16
 
Buy2
 
Hold2
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Jean-Jacques Bienaime
Director, Chief Executive Officer
(18,750)
Sell
May 16, 2018
Jean-Jacques Bienaime
Director, Chief Executive Officer
(18,750)
Sell
May 15, 2018
Jean-Jacques Bienaime
Director, Chief Executive Officer
(18,750)
Sell
May 14, 2018
Jean-Jacques Bienaime
Director, Chief Executive Officer
(18,750)
Sell
May 11, 2018
Brian Mueller
SVP, Corporate Controller
(2,450)
Sell
May 10, 2018

Recent SEC Filings

Insider Buy/Sell
May 18, 2018
Insider Buy/Sell
May 18, 2018
Insider Buy/Sell
May 17, 2018
Insider Buy/Sell
May 16, 2018
Insider Buy/Sell
May 14, 2018

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: [email protected]

Global Medical Information

Contact Global Medical Information